Home/Filings/4/0001437749-12-009900
4//SEC Filing

Mehta Nozer 4

Accession 0001437749-12-009900

CIK 0000352747other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:24 PM ET

Size

6.9 KB

Accession

0001437749-12-009900

Insider Transaction Report

Form 4
Period: 2012-09-27
Mehta Nozer
Vice Pres. Biological R&D
Transactions
  • Award

    Stock Option

    2012-09-27+190,601768,181 total
    Exercise: $0.25Exp: 2022-09-26Common Stock (190,601 underlying)
  • Award

    Stock Option

    2012-09-27+630,8751,399,056 total
    Exercise: $0.10From: 2013-09-27Exp: 2022-09-26Common Stock (630,875 underlying)
Footnotes (1)
  • [F1]95,300 stock options will become exercisable on August 1, 2013 and 95,301 stock options will become exercisable on August 1, 2014

Issuer

UNIGENE LABORATORIES INC

CIK 0000352747

Entity typeother

Related Parties

1
  • filerCIK 0001319276

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:24 PM ET
Size
6.9 KB